Author:
Mushtaq Shazad,Warner Marina,Johnson Alan P.,Livermore David M.
Publisher
Oxford University Press (OUP)
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)
Reference6 articles.
1. Leighton, A., Gottlieb, A. B., Dorr, M. B. et al. (2004). Tolerability, pharmacokinetics, and serum bactericidal activity of intravenous dalbavancin in healthy volunteers. Antimicrobial Agents and Chemotherapy48, 940–5.
2. Seltzer, E., Dorr, M. B., Goldstein, B. P. et al. (2003). Once-weekly dalbavancin versus standard-of-care antimicrobial regimens for treatment of skin and soft-tissue infections. Clinical Infectious Diseases37, 1298–303.
3. Streit, J. M., Fritsche, T. R., Sader, H. S. et al. (2004). Worldwide assessment of dalbavancin activity and spectrum against over 6,000 clinical isolates. Diagnostic Microbiology and Infectious Diseases48, 137–43.
4. Andrews, J. M. (2004). BSAC standardized disc susceptibility testing method (version 3). Journal of Antimicrobial Chemotherapy53, 713–28.
5. National Committee for Clinical Laboratory Standards. (2003). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically—Sixth Edition: Approved Standard M07-A6. NCCLS, Villanova, PA, USA.
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献